OPKO Health to Report First Quarter 2021 Financial Results on April 28, 2021
MIAMI, April 22, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for...
News
Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma
NEWTOWN, Pa., April 22, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering...
OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
NAPERVILLE, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company,...
Poll: Oral Covid-19 Vaccine Pill Offers a Way to Overcome Vaccine Resistance of Millions of Americans
Nearly 19 million Americans who will decline vaccines would get vaccinated if they had a pill option, Vaxart’s poll finds...
Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application
TORONTO, April 22, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty...
RB Capital Increases Investment in Sunshine Biopharma
MONTREAL, April 22, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research,...
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Next data readout for ASLAN004 in the treatment of patients with moderate to severe atopic dermatitis anticipated in the third...
Intra-Cellular Therapies Announces Investor Webcast and Presentations on Lumateperone Programs at the Upcoming American Psychiatric Association (APA) Annual Meeting
Webcast to be Held Tuesday, May 4, 2021 at 2:00 p.m. EDT Webcast Will Feature Key Opinion Leader, Dr. Roger...
Akari Therapeutics Announces Poster Presentation of Phase II Bullous Pemphigoid Disease and Phase III Trial Design at American Academy of Dermatology Association Virtual Meeting Experience
NEW YORK and LONDON, April 22, 2021 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on...
VitalHub Announces Integration and Partnership with PointClickCare Technologies
TORONTO, April 22, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSXV: VHI) is pleased to announce that it is now a...
MediWound Enrolls First Patient in Phase 2 Pharmacology Study of EscharEx
Data Expected Second-Half 2021YAVNE, Israel, April 22, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused...
The Joint Corp. to Host Conference Call on Thursday, May 6th to Discuss First Quarter 2021 Results
SCOTTSDALE, Ariz., April 22, 2021 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of...
Kraig Biocraft Laboratories subsidiary, Spydasilk Enterprises, files for registration of multiple Spider Silk brand trademarks
Kings Group, Kraig’s joint venture partner, leads branding, with unique trademarks centered on spider silkANN ARBOR, Mich., April 22, 2021...
MeMed Key® Wins Red Dot Award for High Design Quality
MeMed Key® Wins Red Dot Award for High Design Quality HAIFA, April 22, 2021- frog, a leading global design...
ProQR Announces Participation in Upcoming Kempen Life Sciences Conference
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company...
Bio-Path Announces Publication in Biomedicines
Peer Reviewed Manuscript Highlights Challenges of Antisense Oligonucleotide Drug Delivery and Benefits of PrexigebersenHOUSTON, April 22, 2021 (GLOBE NEWSWIRE) --...
Progressive Care Commences COVID-19 Vaccinations
MIAMI, FL, April 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”),...
Yumanity Therapeutics’ YTX-7739 Achieved Target Engagement at Doses That Were Generally Well Tolerated in a Phase 1a Multiple Ascending Dose Study in Healthy Volunteers
YTX-7739 is Yumanity’s lead product candidate in clinical development for the treatment of Parkinson’s diseaseBOSTON, April 22, 2021 (GLOBE NEWSWIRE)...
Global WholeHealth Partners Corp. (OTC:GWHP) Partners with Nunzia Pharmaceutical Inc., Opening New Avenues of Revenue and Products for Global
SAN CLEMENTE, CA, April 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Global WholeHealth Partners Corp. (OTC: GWHP), a multinational...
CareDx to Debut Multicenter Data on AlloSure® Lung, an Analytically and Clinically Validated Biomarker of Graft Injury for Lung Transplant Patients
Leading transplant clinicians to present data in seven abstracts at International Society of Heart and Lung Transplantation Annual MeetingSOUTH SAN...